Goodman Corey S - Net Worth and Insider Trading

Goodman Corey S Net Worth

The estimated net worth of Goodman Corey S is at least $165 Million dollars as of 2024-05-10. Goodman Corey S is the Executive Chairman of ALX Oncology Holdings Inc and owns about 9,867,295 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $165 Million. Details can be seen in Goodman Corey S's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Goodman Corey S has not made any transactions after 2020-07-21 and currently still holds the listed stock(s).

Transaction Summary of Goodman Corey S

To

Goodman Corey S Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Goodman Corey S owns 10 companies in total, including Metacrine Inc (MTCR) , Checkmate Pharmaceuticals Inc (CMPI) , and ALX Oncology Holdings Inc (ALXO) among others .

Click here to see the complete history of Goodman Corey S’s form 4 insider trades.

Insider Ownership Summary of Goodman Corey S

Ticker Comapny Transaction Date Type of Owner
MTCR Metacrine Inc 2020-09-18 10 percent owner & other: See Remarks
CMPI Checkmate Pharmaceuticals Inc 2020-08-06 10 percent owner
ALXO ALX Oncology Holdings Inc 2020-07-21 director & 10 percent owner & other: Executive Chairman
2020-07-01 10 percent owner
2019-03-27 10 percent owner
2007-10-04 Senior Vice President
2021-04-22 10 percent owner
2022-05-25 10 percent owner
2021-10-20 10 percent owner & other: See Remarks
2023-09-14 10 percent owner

Goodman Corey S Latest Holdings Summary

Goodman Corey S currently owns a total of 1 stock. Goodman Corey S owns 9,867,295 shares of ALX Oncology Holdings Inc (ALXO) as of July 21, 2020, with a value of $165 Million.

Latest Holdings of Goodman Corey S

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXO ALX Oncology Holdings Inc 2020-07-21 9,867,295 16.68 164,586,481

Holding Weightings of Goodman Corey S


Goodman Corey S Form 4 Trading Tracker

According to the SEC Form 4 filings, Goodman Corey S has made a total of 1 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 850,000 shares on July 21, 2020, which cost Goodman Corey S around $16 Million.

Insider Trading History of Goodman Corey S

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Goodman Corey S Trading Performance

GuruFocus tracks the stock performance after each of Goodman Corey S's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goodman Corey S is 38.74%. GuruFocus also compares Goodman Corey S's trading performance to market benchmark return within the same time period. The performance of stocks bought by Goodman Corey S within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Goodman Corey S's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Goodman Corey S

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 46.47
Relative Return to S&P 500(%) 42.18

Goodman Corey S Ownership Network

Ownership Network List of Goodman Corey S

No Data

Ownership Network Relation of Goodman Corey S


Goodman Corey S Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Goodman Corey S is the 10 percent owner & other: See Remarks of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net sale of 380,605 shares made by Preston Klassen , a net purchase of 271,605 shares made by Braden Michael Leonard , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 271,605 shares were bought by its insiders, resulting in a net sale of 216,054 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Metacrine Inc Insider Transactions

No Available Data

Goodman Corey S Mailing Address

Above is the net worth, insider trading, and ownership report for Goodman Corey S. You might contact Goodman Corey S via mailing address: 1700 Owens Street, Suite 595, San Francisco Ca 94158.

Discussions on Goodman Corey S

No discussions yet.